Verrica Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $5,092 | $14,344 | $12,702 | $3,439 |
Gross Profit | 3,691 | 13,235 | 12,362 | 3,016 |
EBITDA | -8,365 | 2,004 | 2,534 | -7,331 |
EBIT | -8,555 | 1,820 | 2,335 | -7,539 |
Net Income | -8,074 | -274 | 204 | -9,742 |
Net Change In Cash | 5,092 | 14,344 | 12,702 | 3,439 |
Free Cash Flow | -4,591 | 9,685 | -10,044 | -12,677 |
Cash | 30,147 | 21,097 | 15,396 | 29,595 |
Basic Shares | 10,652 | 9,490 | 9,490 | 9,483 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $35,577 | $7,566 | $5,124 | $9,032 |
Gross Profit | 32,136 | 4,826 | 4,378 | 8,307 |
EBITDA | -11,158 | -65,898 | -62,197 | -21,597 |
EBIT | -11,939 | -67,167 | -63,033 | -22,315 |
Net Income | -17,886 | -76,579 | -66,995 | -24,487 |
Net Change In Cash | 35,577 | 7,566 | 5,124 | 9,032 |
Cost of Revenue | 18,521 | |||
Free Cash Flow | -17,627 | -60,954 | -38,939 | -18,952 |
Cash | 30,147 | 46,329 | 69,547 | 34,273 |
Basic Shares | 10,652 | 5,180 | 4,534 | 3,416 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.51 |
2025-09-30 | $0.13 |
2025-06-30 | $0.02 |
2025-03-31 | -$0.10 |
